Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Abeona Therapeutics (ABEO) over the last 8 years, with Q3 2025 value amounting to -$0.1.
- Abeona Therapeutics' EPS (Weighted Average and Diluted) rose 8412.7% to -$0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.23, marking a year-over-year increase of 14572.49%. This contributed to the annual value of -$1.55 for FY2024, which is 3878.42% up from last year.
- Abeona Therapeutics' EPS (Weighted Average and Diluted) amounted to -$0.1 in Q3 2025, which was up 8412.7% from $1.71 recorded in Q2 2025.
- Abeona Therapeutics' EPS (Weighted Average and Diluted)'s 5-year high stood at $1.71 during Q2 2025, with a 5-year trough of -$1.16 in Q1 2024.
- In the last 4 years, Abeona Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.51 in 2023 and averaged -$0.3.
- As far as peak fluctuations go, Abeona Therapeutics' EPS (Weighted Average and Diluted) crashed by 16764.71% in 2023, and later surged by 75769.23% in 2025.
- Abeona Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.9 in 2022, then increased by 14.03% to -$0.78 in 2023, then skyrocketed by 70.95% to -$0.23 in 2024, then surged by 55.67% to -$0.1 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.1 in Q3 2025, compared to $1.71 in Q2 2025 and -$0.24 in Q1 2025.